On Friday, Larimar Therapeutics Inc (NASDAQ: LRMR) was 5.64% up from the session before settling in for the closing price of $3.37. A 52-week range for LRMR has been $1.61 – $6.91.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 50.78%. When this article was written, the company’s average yearly earnings per share was at -48.77%. With a float of $47.71 million, this company’s outstanding shares have now reached $85.59 million.
Larimar Therapeutics Inc (LRMR) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Larimar Therapeutics Inc stocks. The insider ownership of Larimar Therapeutics Inc is 44.26%, while institutional ownership is 57.32%. The most recent insider transaction that took place on Jul 31 ’25, was worth 30,000,000. In this transaction Director of this company bought 9,375,000 shares at a rate of $3.20, taking the stock ownership to the 9,538,945 shares.
Larimar Therapeutics Inc (LRMR) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.45 earnings per share (EPS) during the time that was less than consensus figure (set at -0.32) by -0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -48.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.92% during the next five years compared to 50.78% growth over the previous five years of trading.
Larimar Therapeutics Inc (NASDAQ: LRMR) Trading Performance Indicators
You can see what Larimar Therapeutics Inc (LRMR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.93, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -1.88 in one year’s time.
Technical Analysis of Larimar Therapeutics Inc (LRMR)
The latest stats from [Larimar Therapeutics Inc, LRMR] show that its last 5-days average volume of 1.52 million was superior to 1.51 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 49.50%.
During the past 100 days, Larimar Therapeutics Inc’s (LRMR) raw stochastic average was set at 23.31%, which indicates a significant decrease from 53.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.29 in the past 14 days, which was lower than the 0.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.05, while its 200-day Moving Average is $3.19. Now, the first resistance to watch is $3.69. This is followed by the second major resistance level at $3.82. The third major resistance level sits at $4.01. If the price goes on to break the first support level at $3.38, it is likely to go to the next support level at $3.19. The third support level lies at $3.06 if the price breaches the second support level.
Larimar Therapeutics Inc (NASDAQ: LRMR) Key Stats
There are 82,778K outstanding shares of the company, which has a market capitalization of 304.70 million. As of now, sales total 0 K while income totals -80,600 K. Its latest quarter income was 0 K while its last quarter net income were -47,710 K.
